Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact.

Macinnis RJ, Antoniou AC, Eeles RA, Severi G, Al Olama AA, McGuffog L, Kote-Jarai Z, Guy M, O'Brien LT, Hall AL, Wilkinson RA, Sawyer E, Ardern-Jones AT, Dearnaley DP, Horwich A, Khoo VS, Parker CC, Huddart RA, Van As N, McCredie MR, English DR, Giles GG, Hopper JL, Easton DF.

Genet Epidemiol. 2011 Sep;35(6):549-56. doi: 10.1002/gepi.20605. Epub 2011 Jul 18.

2.

Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations.

Dite GS, Whittemore AS, Knight JA, John EM, Milne RL, Andrulis IL, Southey MC, McCredie MR, Giles GG, Miron A, Phipps AI, West DW, Hopper JL.

Br J Cancer. 2010 Sep 28;103(7):1103-8. doi: 10.1038/sj.bjc.6605876. Epub 2010 Sep 7.

3.

Consequences in women of participating in a study of the natural history of cervical intraepithelial neoplasia 3.

McCredie MR, Paul C, Sharples KJ, Baranyai J, Medley G, Skegg DC, Jones RW.

Aust N Z J Obstet Gynaecol. 2010 Aug;50(4):363-70. doi: 10.1111/j.1479-828X.2010.01170.x.

PMID:
20716265
4.

Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study.

Mouchawar J, Korch C, Byers T, Pitts TM, Li E, McCredie MR, Giles GG, Hopper JL, Southey MC.

Cancer Res. 2010 Jun 15;70(12):4795-800. doi: 10.1158/0008-5472.CAN-09-0851. Epub 2010 May 25.

5.

Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study.

van Leeuwen MT, Webster AC, McCredie MR, Stewart JH, McDonald SP, Amin J, Kaldor JM, Chapman JR, Vajdic CM, Grulich AE.

BMJ. 2010 Feb 11;340:c570. doi: 10.1136/bmj.c570.

6.

Cutaneous melanoma is related to immune suppression in kidney transplant recipients.

Vajdic CM, van Leeuwen MT, Webster AC, McCredie MR, Stewart JH, Chapman JR, Amin J, McDonald SP, Grulich AE.

Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2297-303. doi: 10.1158/1055-9965.EPI-09-0278. Epub 2009 Jul 21.

7.

The pattern of excess cancer in dialysis and transplantation.

Stewart JH, Vajdic CM, van Leeuwen MT, Amin J, Webster AC, Chapman JR, McDonald SP, Grulich AE, McCredie MR.

Nephrol Dial Transplant. 2009 Oct;24(10):3225-31. doi: 10.1093/ndt/gfp331. Epub 2009 Jul 8.

PMID:
19589786
8.

Prostate cancer segregation analyses using 4390 families from UK and Australian population-based studies.

MacInnis RJ, Antoniou AC, Eeles RA, Severi G, Guy M, McGuffog L, Hall AL, O'Brien LT, Wilkinson RA, Dearnaley DP, Ardern-Jones AT, Horwich A, Khoo VS, Parker CC, Huddart RA, McCredie MR, Smith C, Southey MC, Staples MP, English DR, Hopper JL, Giles GG, Easton DF.

Genet Epidemiol. 2010 Jan;34(1):42-50. doi: 10.1002/gepi.20433.

PMID:
19492347
9.

Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation.

van Leeuwen MT, Grulich AE, Webster AC, McCredie MR, Stewart JH, McDonald SP, Amin J, Kaldor JM, Chapman JR, Vajdic CM.

Blood. 2009 Jul 16;114(3):630-7. doi: 10.1182/blood-2009-02-202507. Epub 2009 May 14.

10.

An international case-control study of maternal diet during pregnancy and childhood brain tumor risk: a histology-specific analysis by food group.

Pogoda JM, Preston-Martin S, Howe G, Lubin F, Mueller BA, Holly EA, Filippini G, Peris-Bonet R, McCredie MR, Cordier S, Choi W.

Ann Epidemiol. 2009 Mar;19(3):148-60. doi: 10.1016/j.annepidem.2008.12.011.

11.

Immunosuppression and other risk factors for lip cancer after kidney transplantation.

van Leeuwen MT, Grulich AE, McDonald SP, McCredie MR, Amin J, Stewart JH, Webster AC, Chapman JR, Vajdic CM.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):561-9. doi: 10.1158/1055-9965.EPI-08-0919. Epub 2009 Feb 3.

12.

Predictors of mammographic density: insights gained from a novel regression analysis of a twin study.

Dite GS, Gurrin LC, Byrnes GB, Stone J, Gunasekara A, McCredie MR, English DR, Giles GG, Cawson J, Hegele RA, Chiarelli AM, Yaffe MJ, Boyd NF, Hopper JL.

Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3474-81. doi: 10.1158/1055-9965.EPI-07-2636.

13.

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.

McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, Skegg DC.

Lancet Oncol. 2008 May;9(5):425-34. doi: 10.1016/S1470-2045(08)70103-7. Epub 2008 Apr 11.

PMID:
18407790
14.

Is MSH2 a breast cancer susceptibility gene?

Wong EM, Tesoriero AA, Pupo GM; kConFab; ABCFS, McCredie MR, Giles GG, Hopper JL, Mann GJ, Goldgar DE, Southey MC.

Fam Cancer. 2008;7(2):151-5. Epub 2007 Oct 6.

PMID:
17922223
15.

Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002.

Stewart JH, McCredie MR, Williams SM, Jager KJ, Trpeski L, McDonald SP; ESRD Incidence Study Group.

Nephrology (Carlton). 2007 Oct;12(5):520-7.

PMID:
17803478
16.

Increased incidence of squamous cell carcinoma of eye after kidney transplantation.

Vajdic CM, van Leeuwen MT, McDonald SP, McCredie MR, Law M, Chapman JR, Webster AC, Kaldor JM, Grulich AE.

J Natl Cancer Inst. 2007 Sep 5;99(17):1340-2. Epub 2007 Aug 14.

PMID:
17698951
17.

Is BRCA2 c.9079 G>A a predisposing variant for early onset breast cancer?

Hammet F, George J, Tesoriero AA, Jenkins MA, Schroen C, Smith L, Grabosch-Meehan A, Dite G, McCredie MR, Giles GG, Tavtigian SV, Hopper JL, Southey MC.

Breast Cancer Res Treat. 2008 May;109(1):177-9. Epub 2007 Jun 5. No abstract available.

PMID:
17549625
18.

Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.

Delahunt B, Sika-Paotonu D, Bethwaite PB, McCredie MR, Martignoni G, Eble JN, Jordan TW.

Am J Surg Pathol. 2007 Jun;31(6):957-60.

PMID:
17527087
19.

The evolution of collagen expression in sarcomatoid renal cell carcinoma.

Delahunt B, Bethwaite PB, McCredie MR, Nacey JN.

Hum Pathol. 2007 Sep;38(9):1372-7. Epub 2007 May 22.

PMID:
17521699
20.

A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk.

Spurdle AB, Chang JH, Byrnes GB, Chen X, Dite GS, McCredie MR, Giles GG, Southey MC, Chenevix-Trench G, Hopper JL.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):769-74.

21.

BRCA1 promoter deletions in young women with breast cancer and a strong family history: a population-based study.

Smith LD, Tesoriero AA, Ramus SJ, Dite G, Royce SG, Giles GG, McCredie MR, Hopper JL, Southey MC.

Eur J Cancer. 2007 Mar;43(5):823-7. Epub 2007 Feb 21.

22.

A common coding variant in CASP8 is associated with breast cancer risk.

Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, Pooley KA, Scollen S, Baynes C, Ponder BA, Chanock S, Lissowska J, Brinton L, Peplonska B, Southey MC, Hopper JL, McCredie MR, Giles GG, Fletcher O, Johnson N, dos Santos Silva I, Gibson L, Bojesen SE, Nordestgaard BG, Axelsson CK, Torres D, Hamann U, Justenhoven C, Brauch H, Chang-Claude J, Kropp S, Risch A, Wang-Gohrke S, Schürmann P, Bogdanova N, Dörk T, Fagerholm R, Aaltonen K, Blomqvist C, Nevanlinna H, Seal S, Renwick A, Stratton MR, Rahman N, Sangrajrang S, Hughes D, Odefrey F, Brennan P, Spurdle AB, Chenevix-Trench G; Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer, Beesley J, Mannermaa A, Hartikainen J, Kataja V, Kosma VM, Couch FJ, Olson JE, Goode EL, Broeks A, Schmidt MK, Hogervorst FB, Van't Veer LJ, Kang D, Yoo KY, Noh DY, Ahn SH, Wedrén S, Hall P, Low YL, Liu J, Milne RL, Ribas G, Gonzalez-Neira A, Benitez J, Sigurdson AJ, Stredrick DL, Alexander BH, Struewing JP, Pharoah PD, Easton DF; Breast Cancer Association Consortium.

Nat Genet. 2007 Mar;39(3):352-8. Epub 2007 Feb 11. Erratum in: Nat Genet. 2007 May;39(5):688.

PMID:
17293864
23.

Cancer incidence before and after kidney transplantation.

Vajdic CM, McDonald SP, McCredie MR, van Leeuwen MT, Stewart JH, Law M, Chapman JR, Webster AC, Kaldor JM, Grulich AE.

JAMA. 2006 Dec 20;296(23):2823-31.

PMID:
17179459
24.

Review of cytologic slides from the national women's hospital, New Zealand, cohort of women with cervical intraepithelial neoplasia 3 diagnosed in 1955-1976.

McCredie MR, Medley G, Sharples KJ, Jones RW, Baranyai J, Paul C, Skegg DC.

Acta Cytol. 2006 Nov-Dec;50(6):632-6.

PMID:
17152274
25.

Divergent trends in the incidence of end-stage renal disease due to Type 1 and Type 2 diabetes in Europe, Canada and Australia during 1998-2002.

ESRD Incidence Study Group, Stewart JH, McCredie MR, Williams SM.

Diabet Med. 2006 Dec;23(12):1364-9.

PMID:
17116189
26.

BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50.

Haile RW, Thomas DC, McGuire V, Felberg A, John EM, Milne RL, Hopper JL, Jenkins MA, Levine AJ, Daly MM, Buys SS, Senie RT, Andrulis IL, Knight JA, Godwin AK, Southey M, McCredie MR, Giles GG, Andrews L, Tucker K, Miron A, Apicella C, Tesoriero A, Bane A, Pike MC; kConFab Investigators; Ontario Cancer Genetics Network Investigators, Whittemore AS.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1863-70. Epub 2006 Oct 4.

27.

Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma.

Sika-Paotonu D, Bethwaite PB, McCredie MR, William Jordan T, Delahunt B.

Am J Surg Pathol. 2006 Sep;30(9):1091-6.

PMID:
16931953
28.

The enigma of hypertensive ESRD: observations on incidence and trends in 18 European, Canadian, and Asian-Pacific populations, 1998 to 2002.

Stewart JH, McCredie MR, Williams SM; Canadian Organ Replacement Register, Fenton SS, Trpeski L; Australia and New Zealand Dialysis and Transplant Registry, McDonald SP; European Renal Association-European Dialysis and Transplant Association Registry, Jager KJ, van Dijk PC; Finnish Registry for Kidney Diseases, Finne P; Swedish Registry for Active Treatment of Uremia, Schon S; Norwegian Renal Registry, Leivestad T; Danish National Registry on Regular Dialysis and Transplantation, Løkkegaard H; Dutch-speaking Belgian Society of Nephrology, Billiouw JM; Austrian Dialysis and Transplant Registry, Kramar R; Basque Renal Patients' Registry, Magaz A; Catalan Renal Registry, Vela E; Valencian Renal Registry, Garcia-Blasco MJ; Hellenic Renal Registry, Ioannidis GA; Malaysian National Renal Registry, Lim YN.

Am J Kidney Dis. 2006 Aug;48(2):183-91.

PMID:
16860183
29.

The heritability of mammographically dense and nondense breast tissue.

Stone J, Dite GS, Gunasekara A, English DR, McCredie MR, Giles GG, Cawson JN, Hegele RA, Chiarelli AM, Yaffe MJ, Boyd NF, Hopper JL.

Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):612-7.

30.

Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002.

ESRD Incidence Study Group, Stewart JH, McCredie MR, Williams SM.

Nephrol Dial Transplant. 2006 Aug;21(8):2178-83. Epub 2006 Apr 4.

PMID:
16595584
31.

A genome wide linkage search for breast cancer susceptibility genes.

Smith P, McGuffog L, Easton DF, Mann GJ, Pupo GM, Newman B, Chenevix-Trench G; kConFab Investigators, Szabo C, Southey M, Renard H, Odefrey F, Lynch H, Stoppa-Lyonnet D, Couch F, Hopper JL, Giles GG, McCredie MR, Buys S, Andrulis I, Senie R; BCFS, BRCAX Collaborators Group, Goldgar DE, Oldenburg R, Kroeze-Jansema K, Kraan J, Meijers-Heijboer H, Klijn JG, van Asperen C, van Leeuwen I, Vasen HF, Cornelisse CJ, Devilee P, Baskcomb L, Seal S, Barfoot R, Mangion J, Hall A, Edkins S, Rapley E, Wooster R, Chang-Claude J, Eccles D, Evans DG, Futreal P, Nathanson KL, Weber BL; Breast Cancer Susceptibility Collaboration (UK), Rahman N, Stratton MR.

Genes Chromosomes Cancer. 2006 Jul;45(7):646-55.

32.

Is there a positive association between mammographic density and bone mineral density?

Dite GS, Wark JD, Giles GG, English DR, McCredie MR, Hopper JL.

Breast Cancer Res. 2006;8(1):401. Epub 2006 Feb 13. No abstract available.

33.

Is there overlap between the genetic determinants of mammographic density and bone mineral density?

Dite GS, Wark JD, Giles GG, English DR, McCredie MR, Hopper JL.

Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2266-8.

34.

A protein-truncating mutation in CYP17A1 in three sisters with early-onset breast cancer.

Hopper JL, Hayes VM, Spurdle AB, Chenevix-Trench G, Jenkins MA, Milne RL, Dite GS, Tesoriero AA, McCredie MR, Giles GG, Southey MC.

Hum Mutat. 2005 Oct;26(4):298-302.

PMID:
16121340
35.

Obesity and outcomes in premenopausal and postmenopausal breast cancer.

Loi S, Milne RL, Friedlander ML, McCredie MR, Giles GG, Hopper JL, Phillips KA.

Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1686-91.

36.

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.

Chang JH, Gertig DM, Chen X, Dite GS, Jenkins MA, Milne RL, Southey MC, McCredie MR, Giles GG, Chenevix-Trench G, Hopper JL, Spurdle AB.

Breast Cancer Res. 2005;7(4):R513-21. Epub 2005 May 12.

37.

The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women.

Montgomery KG, Chang JH, Gertig DM, Dite GS, McCredie MR, Giles GG, Southey MC, Hopper JL, Campbell IG.

Breast Cancer Res. 2005;7(3):R353-6. Epub 2005 Mar 4.

38.

Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry.

Phillips KA, Milne RL, Buys S, Friedlander ML, Ward JH, McCredie MR, Giles GG, Hopper JL.

J Clin Oncol. 2005 Jul 20;23(21):4679-86. Epub 2005 Apr 25.

PMID:
15851764
39.

Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations.

Milne RL, Knight JA, John EM, Dite GS, Balbuena R, Ziogas A, Andrulis IL, West DW, Li FP, Southey MC, Giles GG, McCredie MR, Hopper JL, Whittemore AS.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):350-6.

40.

Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based study.

Keogh LA, Southey MC, Maskiell J, Young MA, Gaff CL, Kirk J, Tucker KM, Rosenthal D, McCredie MR, Giles GG, Hopper JL.

Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2258-63.

41.

Incidence of end-stage renal disease in overseas-born, compared with Australian-born, non-indigenous Australians.

Stewart JH, McCredie MR, McDonald SP.

Nephrology (Carlton). 2004 Aug;9(4):247-52.

PMID:
15363057
42.

Interpreting incidence trends for treated end-stage renal disease: implications for evaluating disease control in Australia.

Stewart JH, McCredie MR, Williams SM, McDonald SP.

Nephrology (Carlton). 2004 Aug;9(4):238-46.

PMID:
15363056
43.

Cytomegalovirus, Epstein-Barr virus and risk of breast cancer before age 40 years: a case-control study.

Richardson AK, Cox B, McCredie MR, Dite GS, Chang JH, Gertig DM, Southey MC, Giles GG, Hopper JL.

Br J Cancer. 2004 Jun 1;90(11):2149-52.

44.

Foods, nutrients and prostate cancer.

Hodge AM, English DR, McCredie MR, Severi G, Boyle P, Hopper JL, Giles GG.

Cancer Causes Control. 2004 Feb;15(1):11-20.

PMID:
14970730
45.

Prognosis of premenopausal breast cancer and childbirth prior to diagnosis.

Phillips KA, Milne RL, Friedlander ML, Jenkins MA, McCredie MR, Giles GG, Hopper JL.

J Clin Oncol. 2004 Feb 15;22(4):699-705.

PMID:
14966094
46.

Prevalence of self-reported arm morbidity following treatment for breast cancer in the Australian Breast Cancer Family Study.

McCredie MR, Dite GS, Porter L, Maskiell J, Giles GG, Phillips KA, Redman S, Hopper JL.

Breast. 2001 Dec;10(6):515-22.

PMID:
14965632
47.

The incidence of treated end-stage renal disease in New Zealand Maori and Pacific Island people and in Indigenous Australians.

Stewart JH, McCredie MR, McDonald SP.

Nephrol Dial Transplant. 2004 Mar;19(3):678-85.

PMID:
14767026
48.

Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors.

Severi G, Sinclair R, Hopper JL, English DR, McCredie MR, Boyle P, Giles GG.

Br J Dermatol. 2003 Dec;149(6):1207-13.

PMID:
14674898
49.

Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status.

McCredie MR, Dite GS, Southey MC, Venter DJ, Giles GG, Hopper JL.

Br J Cancer. 2003 Nov 3;89(9):1661-3.

50.

The HER2 I655V polymorphism and risk of breast cancer in women < age 40 years.

Montgomery KG, Gertig DM, Baxter SW, Milne RL, Dite GS, McCredie MR, Giles GG, Southey MC, Hopper JL, Campbell IG.

Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1109-11.

Supplemental Content

Loading ...
Support Center